Eli Lilly has joined as a defendant in a lawsuit filed by a pharmacy industry group against the Food and Drug Administration (FDA), seeking to end a lawsuit filed by a pharmacy industry group against the Food and Drug Administration (FDA), seeking to end a lawsuit against the Food and Drug Administration (FDA) that seeks to end a lawsuit filed by a pharmacy industry group against the Food and Drug Administration (FDA). He says he wants to end it. A popular GLP-1 treatment. The lawsuit in question concerns the FDA's decision to formally declare a shortage of Mounjaro and Zepbound, both forms of…
|